Cargando…

Denosumab for management of severe hypercalcemia in primary hyperparathyroidism

Hypercalcemic crisis is a severe but rare complication of primary hyperparathyroidism (PHPT), and data on denosumab treatment of patients with this disease is still very limited. The aim of this paper is to investigate the hypocalcemic effect of denosumab in PHPT patients with severe hypercalcemia w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eremkina, Anna, Krupinova, Julia, Dobreva, Ekaterina, Gorbacheva, Anna, Bibik, Ekaterina, Samsonova, Margarita, Ajnetdinova, Alina, Mokrysheva, Natalya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707828/ https://www.ncbi.nlm.nih.gov/pubmed/33112830 http://dx.doi.org/10.1530/EC-20-0380

Ejemplares similares

Serum circulating miRNA‐342‐3p as a potential diagnostic biomarker in parathyroid carcinomas: A pilot study
por: Krupinova, Julia, et al.
Publicado: (2021)

Primary hyperparathyroidism in young patients is associated with metabolic disorders: a prospective comparative study
por: Bibik, Ekaterina E., et al.
Publicado: (2023)

Cardiovascular and metabolic status in patients with primary hyperparathyroidism: a single-center experience
por: Dobreva, Ekaterina A., et al.
Publicado: (2023)

The Russian registry of primary hyperparathyroidism, latest update
por: Mokrysheva, Natalia G., et al.
Publicado: (2023)

The Russian Registry of Chronic Hypoparathyroidism
por: Kovaleva, Elena V., et al.
Publicado: (2022)

The role of menin in bone pathology
por: Gorbacheva, Anna, et al.
Publicado: (2022)

Multiple Metastases of Parathyroid and Papillary Thyroid Carcinoma in a Female Patient Treated with Long-Term Hemodialysis
por: Krupinova, Julia, et al.
Publicado: (2023)

Mathematical model for preoperative differential diagnosis for the parathyroid neoplasms
por: Krupinova, Julia A., et al.
Publicado: (2022)

ODP084 Denosumab as a therapuetic modality in management of primary hyperparathyroidism induced severe hypercalcemia
por: Mangaraj, Swayamsidha, et al.
Publicado: (2022)

A Case of Pregnancy Complicated by Primary Hyperparathyroidism Due to a Parathyroid Adenoma
por: Mokrysheva, Natalia G., et al.
Publicado: (2019)

Denosumab can be used successfully as a bridge to surgery in patients with severe hypercalcemia due to primary hyperparathyroidism
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2021)

Hypercalcemia upon denosumab withdrawal in primary hyperparathyroidism: a case report and literature review
por: Camponovo, C., et al.
Publicado: (2020)

Denosumab as a Bridge to Surgery in a Patient with Severe Hypercalcemia Due to Primary Hyperparathyroidism in the Setting of Renal Dysfunction
por: Rajan, Remya, et al.
Publicado: (2019)

Silent intrathyroid parathyroid carcinoma
por: Kim, Ekaterina, et al.
Publicado: (2023)

Parathyromatosis Recurrent Hyperparathyroidism and Refractory Hypercalcemia Successfully Managed With Addition of Denosumab: A Case Report
por: Alhammad, Zahrah Abbas, et al.
Publicado: (2021)

Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome
por: Mamedova, Elizaveta, et al.
Publicado: (2017)

Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic
por: Alfadhli, Eman M.
Publicado: (2021)

Concurrent Primary Hyperparathyroidism and Sarcoidosis in a Patient With Severe Hypercalcemia
por: Ayyad, Mohammed, et al.
Publicado: (2023)

Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis
por: Rajput, Swati, et al.
Publicado: (2023)

A Novel GNAS Mutation in a Patient with Ia Pseudohypoparathyroidism (iPPSD2) Phenotype
por: Gorbacheva, Anna, et al.
Publicado: (2023)

Vitamin A and Hydrochlorothiazide Causing Severe Hypercalcemia in a Patient With Primary Hyperparathyroidism
por: Varghese, Ron T., et al.
Publicado: (2019)

Symptomatic Hypercalcemia in Patients with Primary Hyperparathyroidism Is Associated with Severity of Disease, Polypharmacy, and Comorbidity
por: Aresta, C., et al.
Publicado: (2019)

Lithium-induced Hyperparathyroidism and Hypercalcemia
por: Naramala, Srikanth, et al.
Publicado: (2019)

SAT-499 Denosumab for Treatment of Hypercalcemia in Myelofibrosis
por: Wong, Beatrice, et al.
Publicado: (2019)

Multifactorial Hypercalcemia and Literature Review on Primary Hyperparathyroidism Associated with Lymphoma
por: Maletkovic, Jelena, et al.
Publicado: (2014)

Metabolic acidosis-induced hypercalcemia in an azotemic patient with primary hyperparathyroidism
por: Rastegar, Mandana, et al.
Publicado: (2014)

A Case of Gitelman Syndrome with Hypercalcemia Secondary to Primary Hyperparathyroidism
por: Alnahas, Zeinab, et al.
Publicado: (2022)

Hypovitaminosis D masking hypercalcemia in primary hyperparathyroidism: case report
por: Elsherbiny, Tamer Mohamed
Publicado: (2023)

MON-LB64 Primary Hyperparathyroidism With Severe Hypercalcemia During Pregnancy: A Challenging Diagnosis and Management
por: George, Gemy M, et al.
Publicado: (2020)

PSAT214 Management of Hyperparathyroidism Associated with Severe Hypercalcemia Presenting During Labour
por: Mendez, Juan Vasquez, et al.
Publicado: (2022)

Severe hypercalcemia and a pelvic brown tumor in an adolescent with primary hyperparathyroidism: a case report
por: Legault, O., et al.
Publicado: (2020)

Severe Hypercalcemia Due to Primary Hyperparathyroidism and Heterozygous Pathogenic Variant of CYP24A1
por: Liu, Jannel, et al.
Publicado: (2023)

Symptomatic Rebound Hypercalcemia After Denosumab Discontinuation in a Pediatric Patient With Cherubism
por: Marpuri, Ian, et al.
Publicado: (2021)

Diabetes due to recurrent pancreatitis secondary to hypercalcemia due to primary hyperparathyroidism
por: Chakrabarti, Sumit Kumar, et al.
Publicado: (2013)

SUN-496 A Perioperative Risk For Exacerbation of Hypercalcemia in Primary Hyperparathyroidism
por: Tezuka, Yuta, et al.
Publicado: (2019)

Hypercalcemia due to Co-Occurring Metastatic Breast Cancer and Primary Hyperparathyroidism
por: Khubaib, Mohammad U, et al.
Publicado: (2021)

Hypercalcemia following discontinuation of denosumab therapy: A systematic review
por: Horiuchi, Keisuke, et al.
Publicado: (2021)

Rebound Hypercalcemia After Denosumab Therapy in a Child With Cherubism
por: Litao, Melissa Kaori S, et al.
Publicado: (2021)

Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia
por: Abd Jalil, Afdhal Afiq, et al.
Publicado: (2021)

SUN-514 Severe Hypophosphatemia and Worsening Secondary Hyperparathyroidism Following Treatment with Denosumab
por: Adepoju, Yewande, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_juegd52lahghuaeiqscfe7q3h1